Form: EFFECT

Notice of Effectiveness

January 20, 2026

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Notice of Effectiveness

Effectiveness Date: January 20, 2026 9:00 A.M.
Form: S-3
CIK: 0001534120
Company Name: Avalo Therapeutics, Inc.
File Number: 333-292614